EuKonvis Bio-B (01477.HK): OT-703 has been approved to conduct real-world research in Boao, Hainan.

Wisdom Financial APP News, Euclidean Vision Bio-B (01477.HK) announced that the group's product OT-703 (ILUVIEN, a non-biodegradable fluocinolone acetonide intravitreal implant) has recently been approved for real-world research in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan Province, China, used to treat diabetic macular edema (DME).